Elisa Landín-Rey

Dr. Elisa Landín-Rey

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Respiratory Medicine
Verified
Journal Article
Closed access
JÁJosé M. Álvarez-Dobaño
José M. Álvarez-Dobaño
CGCarlota García
Carlota García
GAGerardo Atienza
Gerardo Atienza
MNMaria Elena Toubes Navarro
Maria Elena Toubes Navarro
NRNuria Rodríguez-Núñez
Nuria Rodríguez-Núñez
LVLuis G. Valdés
Luis G. Valdés

13 November 2024 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
NRNuria Rodríguez-Núñez
Nuria Rodríguez-Núñez
FGFrancisco Gude
Francisco Gude
LFLucía Ferreiro
Lucía Ferreiro
ELElisa Landín-Rey
Elisa Landín-Rey
MCMaría Carreiras-Cuiña
María Carreiras-Cuiña
LVLuis G. Valdés
Luis G. Valdés
Introduction: The characteristics and clinical relevance of pleural effusion (PLEF) in acute pulmonary embolism (APE) are not fully understood. Methods: A single-centre, retrospective study was performed of patients admitted with APE classified according to the subsequent development or not of PLEF. A model was built to predict PLEF and its impact on 30-day all-cause mortality was investigated. Results: A total of 1602 patients with APE were included (median age, 74 (61, 82) years; 674 men (42.1%); 382 (23.8%) with PLEF). PLEF was associated with a higher number of comorbidities (p=0.015); more peripheral APE (0.001); a higher frequency of pulmonary infarctions (p<0.001) and higher 30-day all-cause mortality (p=0.004) compared with those without PLEF. Bilateral PLEFs, as compared with unilateral, were associated with a higher number of comorbidities (p=0.009); more severe (simplified Pulmonary Embolism Severity Index ≥1; p<0.001) and higher 30-day all-cause mortality (p<0.001). On multivariate analysis, the presence of PLEF was associated with atrial fibrillation (OR 2.00; 95% CI 1.32 to 3.02), congestive heart failure (OR 3.00; 95% CI 1.81 to 5.00), pulmonary infarction (OR 3.19; 95% CI 2.38 to 4.29) and a Charlson index ≥3 (OR 1.59; 95% CI 1.03 to 2.45). The predictive model for PLEF had a moderate power of discrimination (area under the curve, AUC 0.76; 95% CI 0.73 to 0.79), whereas the predictive model for mortality showed a good predictive power (AUC 0.89; 95% CI 0.86 to 0.93). The presence of PLEF doubles the probability of death (OR 2.02; 95% CI 1.11 to 3.68). When PLEF is bilateral, the probability of death is four times higher, as compared with unilateral PLEF (OR 4.07; 95% CI 1.53 to 10.85; AUC 0.90; 95% CI 0.84 to 0.95). Conclusions: A significant number of APE patients develop PLEF. The model showed a good power of discrimination for the prediction of mortality. The probability of death from APE doubles in the presence of PLEF. Patients with APE and concomitant bilateral PLEF have a fourfold higher risk of mortality, as compared with patients with concomitant unilateral PLEF.

28 November 2025 in Respiratory Medicine
Verified
Journal Article
Open access
TBTara Pereiro Brea
Tara Pereiro Brea
CSCarlos Zamarrón Sanz
Carlos Zamarrón Sanz
ÓLÓscar Lado-Baleato
Óscar Lado-Baleato
FGFrancisco Gude
Francisco Gude
CCCarlos Rábade Castedo
Carlos Rábade Castedo
LVLuis G. Valdés
Luis G. Valdés
Chronic obstructive pulmonary disease (COPD) is frequently associated with cardiovascular diseases (CVD), which may adversely affect the prognosis of these patients. To confirm that individuals with COPD and CVD utilize more healthcare resources, require more frequent hospitalizations, and have higher mortality rates compared to those without these comorbidities. Population-based study including 7391 COPD patients, classified into four groups according to the presence of heart failure (HF) and ischemic heart disease (IHD). Adjusted logistic regression and proportional hazards models were performed. Of the patients, 86.3 % (6378) had COPD alone; 8.1 % (601) had COPD + HF; 3.9 % (290) had COPD + IHD; and 1.7 % (122) had all three conditions. Groups with CVD exhibited older age, higher cardiovascular risk, and increased mortality. Hospitalization was associated with older age, male sex, fewer spirometry tests performed in primary care, and the use of home oxygen therapy and non-invasive ventilation, and was linked to higher mortality compared to non-hospitalized patients. Mortality was higher among patients with COPD and CVD. It was associated with more emergency department visits, more hospital admissions, increased use of chest X-rays and CT scans, and a higher prevalence of depression. Conversely, it was also related to lower rates of vaccination, fewer spirometry tests in primary care, reduced dispensing of inhaled medications, and overall lower pharmaceutical expenditure. The coexistence of COPD and CVD identifies subgroups of patients with poorer prognosis and increased healthcare resource utilization. Multidisciplinary management and prevention strategies are essential to improve outcomes and healthcare efficiency.

8 January 2025 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
ELElisa Landín-Rey
Elisa Landín-Rey
MTMaria Elena Toubes-Navarro
Maria Elena Toubes-Navarro
MDMiguel Dominguez-Robla
Miguel Dominguez-Robla
MRMaria Rey-Bascuas
Maria Rey-Bascuas
LVLuis Valdes-Cuadrado
Luis Valdes-Cuadrado
Introduction: Infective thoracic aortic aneurysms are uncommon, especially presenting with haemoptysis. Case presentation: We report the case of an 81-year-old male who presented with fever and pleuritic chest pain and was initially misdiagnosed with community-acquired pneumonia. A CT scan later revealed a saccular, ruptured thoracic aortic aneurysm. Despite antibiotic therapy, the patient developed haemoptysis, necessitating thoracic endovascular aortic repair (TEVAR). Post-procedure, the patient showed significant clinical improvement and was discharged in stable condition 45 days later. Conclusions: Infected thoracic aortic aneurysms presenting as haemoptysis are exceptionally rare but life-threatening. Early clinical suspicion (manifested by haemoptysis, fever and thoracic pain) is essential, particularly in patients with risk factors such as immunosuppression or previous infections. This case emphasizes the importance of prompt diagnosis and intervention, along with the use of appropriate imaging techniques to reduce morbidity and mortality associated with this rare yet severe condition.